The top official of the Drug Enforcement Administration (DEA), has confirmed that spores which produce magic mushrooms, are not federally illegal on their own.
Terrence Boos, Chief of DEA’s Drug & Chemical Evaluation Section, was asked by attorney Michael McGuire about the legal status for the spores. He responded on Tuesday with a clarification of the agency’s stance.
Boos wrote that “if the mushroom spores or any other material does not contain psilocybin, psilocin or any other listed chemical or controlled substance”, the material would not be considered controlled under the Controlled Substances Act.
He said that if the material contained a controlled drug such as psilocybin, or psilocin, at any point in time (for instance, during germination), it would be a controlled material under the CSA, according to the first report by Kight On Cannabis.
The CSA does not explicitly prohibit spores used to make so-called magic mushrooms. Instead, the psilocybin, psilocyn and other key ingredients are listed as Schedule I controlled drugs.
The spores are not controlled by the CSA because they do not contain these specific compounds.
While the spores may technically be legal under federal law, as long as they are not used to create mushrooms that contain psilocybin, or psilocin, some states, such as California and Georgia, do not allow the spores.
The DEA’s letter is still a clarification. Rod Kight, an attorney, pointed out that police continue to arrest people for using or selling spore kits. It’s possible this could be related to another question, whether the kits are classified as “drug paraphernalia,” and that may depend on how they are marketed or utilized.
This latest DEA letter clarifies a long-debated topic. Kight stated that the letter does not open up the door to widespread sale and use of spore kit. “At the very least, both buyers and sellers need to consult an attorney and understand all legal implications.”
While marijuana is illegal under federal law, , the seeds that grow that plant, are not, as long as they contain less than 0.3 percent of THC in dry form.
According to the definition in the 2018 Farm Bill, which legalized non-intoxicating hemp, if the seeds are below that threshold they will be considered federally legal. Boos made this distinction in a January 2022 letter to Shane Pennington, an attorney.
The DEA official also issued another administrative interpretation of the cannabis statute in the past year. He stated that the agency views , the intoxicating delta-8 THC as an illicit Schedule I substance if the cannabinoid is synthesized using federally legal CBD.
Delta-8 THC has been widely available on the market ever since hemp was legalized. These products exist in a legal grey area that is not regulated. Federal law allows cannabinoids that are naturally derived from hemp. It’s common to synthesize the cannabinoid from CBD, as it is a cost-effective method. Nevertheless, some states have taken measures to limit delta-8 THC.
Boos also explained at DEA’s 2023 Supply Chain Conference, in May, that synthetic cannabinoids were banned. He said that DEA was in the process of drafting a final rule that would formally clarify this policy on the recommendation of U.S. Department of Health and Human Services.
Boos told an attorney last year that minor cannabinoids Delta-8 THC -0 and Delta-9 THC -O were prohibited, because they could only be synthesized.
Some experts, however, have disputed DEA’s interpretation of the law on intoxicating cannabinoids derived from hemp. A federal appeals court in 2022 ruled that rules were written so that delta-8 THC was exempted from control because the law was “silent”.
The letter about psychedelic mushrooms spores came after a federal appeals panel denied a request by attorneys for a Washington State physician trying to reschedule psilocybin in the CSA. A three-judge panel of U.S. Court of Appeals, Ninth Circuit, rejected the doctor’s appeal for a rehearing of a previous court decision which returned the matter back to DEA.
The DEA announced recently that it will take another crack at after abandoning the original proposal for 2022. This is a new battle with advocates and researchers who claim these compounds have therapeutic potential.
Separately, the agency has backed away from a proposal that would have banned five different tryptamine-psychedelics by 2022 due to a large pushback from research and advocacy communities .
DEA is also alerting Georgia pharmacies about the illegality of dispensing THC, because it is still a Schedule I substance. This is after Georgia became the first state in the U.S. that allowed pharmacies to offer medical marijuana. Nearly 120 facilities applied to sell cannabis oil.
The government is also calling for even more THC and DMT to be produced for research purposes, than what it originally proposed for 2024. It has raised its quotas on these drugs while keeping the high production goals set for marijuana and other psychoactives.
The DEA has been actively reviewing marijuana’s scheduling since receiving a recommendation by HHS that it be moved from Schedule I to schedule III under the CSA. In a letter sent to Congress in November, the agency stated that retains “the final authority” for any decision regarding cannabis scheduling. This is regardless of HHS recommendations.
Below is the complete DEA Letter regarding psilocybin mushrooms spores:
A new Kentucky bill would legalize marijuana possession, use and home cultivation but not sales
The first time Marijuana Moment published the post DEA confirms that psychedelic mushroom spores are federally legal prior to germination.
